clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Translational Research
Prostate Tumor Progression Aided by Circadian Clock Gene
Coronavirus
Rapid PCR-Based Test Developed to Detect Pneumonia in Patients with Severe…
Molecular Dx
Abnormal MicroRNAs Could Link Brain Injury with Alzheimer’s
Coronavirus
Language Algorithms Shed Light on How Viruses Like SARS-CoV-2 Mutate to…
Precision Medicine
Researchers Activate Antiviral Immune Pathways in Triple Negative Breast Cancers
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Translational Research
Prostate Tumor Progression Aided by Circadian Clock Gene
Coronavirus
Rapid PCR-Based Test Developed to Detect Pneumonia in Patients with Severe…
Molecular Dx
Abnormal MicroRNAs Could Link Brain Injury with Alzheimer’s
New Products
Investigate 30 Immune Markers in a Single Experiment
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Marketplace
Multimedia
All
Webinars
eBooks
eBooks
Cell and Gene Therapy Clinical Trials
Upcoming Webinars
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Upcoming Webinars
Comprehensive Genomic and Immune Profiling to Support Drug Development
On Demand Webinars
Promising COVID-19 Immunotherapy Targets CCR5
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Precision Medicine
Precision Medicine
Precision Medicine
7 days popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Precision Medicine
Six Precision Medicine Companies Making Their Mark in 2020
June 15, 2020
Precision Medicine
Biomarker-Guided Therapy for Newly Diagnosed Glioblastoma Kicks off Phase III Trial
January 8, 2021
Precision Medicine
Gastric Tumor Prognostic Gene Signature Revealed by Single-Cell Transcriptomics
January 6, 2021
Precision Medicine
In Silico Model Predicts COVID-19 Patient Trajectories and Guides Treatment
January 6, 2021
Precision Medicine
LAM Gets FDA Breakthrough Designation for Liver Cancer Liquid Biopsy
September 4, 2019
Precision Medicine
Tempus Raises Additional $200 Million, Inks Collaboration with Bayer
December 11, 2020
Precision Medicine
Caris Life Sciences Raises $310M in Financing
October 28, 2020
Precision Medicine
Genetic Counseling 2.0
November 6, 2019
Precision Medicine
New Combo Therapy Sidesteps MEK Inhibitor Resistance in Cancer Treatment
December 15, 2020
Precision Medicine
U.K. Researchers Develop Method to Predict Medulloblastoma Relapse in Children
November 19, 2020
1
2
3
...
27
Page 1 of 27
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1907-324x160.jpeg "LAM Gets FDA Breakthrough Designation for Liver Cancer Liquid Biopsy")
![Verge Genomics has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. [Source: kentoh/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1787-324x160.jpeg "Tempus Raises Additional $200 Million, Inks Collaboration with Bayer")
